Upsa C

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Upsa C

Property Description
Active Ingredient Sodium Ascorbate
Form Effervescent Tablets (typically)
Pharmacological Class Water-Soluble Vitamin
General Purpose Correcting Vitamin C Deficiency
Origin Synthetic

Upsa C is classified fundamentally as a pharmaceutical preparation containing a Vitamin, belonging to the high-level pharmacological group of Water-Soluble Vitamins and the therapeutic class of Antidyscorbutic Agents. Its identity is centered on its function as an essential nutrient necessary for supporting fundamental physiological processes.

Composition and Form: Sodium Ascorbate vs. Ascorbic Acid

The active ingredient in Upsa C is Sodium Ascorbate (INN: Sodium Ascorbate), a synthetic mineral salt derivative of L-Ascorbic Acid. This preparation is commonly supplied as Effervescent Tablets for oral administration. The use of the salt form is a key differentiator, as the addition of sodium chemically buffers the compound, resulting in a more neutral pH solution. This chemical attribute is clinically recognized for potentially enhancing patient gastrointestinal tolerance compared to pure Ascorbic Acid.

General Purpose: Supporting Essential Physiological Functions

The general purpose of Upsa C is to leverage the active ingredient’s established function as a biological Antioxidant and a crucial Cofactor for vital systemic maintenance. Sodium Ascorbate acts as a powerful Reducing Agent, which is instrumental in protecting cells from oxidative damage. Specifically, the substance is required for the biosynthesis of Collagen, a fundamental structural protein for the integrity of skin, cartilage, and blood vessels. Furthermore, ascorbic acid enhances the absorption of non-heme iron. These actions confirm the medicine serves as a recognized therapeutic option for individuals requiring supplementation to correct or prevent deficiency states.

Regulatory References

  1. PubChem Compound Summary: Sodium Ascorbate
  2. MedlinePlus Drug Information: Ascorbic Acid

What side effects are possible with Upsa C?

Possible Side Effects and Safety Information

The safety profile for preparations containing Sodium Ascorbate (Vitamin C) is documented in official regulatory sources, which classify adverse reactions primarily based on the affected organ system and frequency.

Official Classification of Adverse Reactions

Adverse reactions associated with this medicine are often dose-related and frequently involve the Gastrointestinal disorders system-organ class. Common reactions documented in regulatory labels include nausea, vomiting, diarrhea, abdominal discomfort, and heartburn, which are typically observed at higher intake levels. Serious adverse reactions are generally classified as rare.

System-Organ Class Common Adverse Reactions
Gastrointestinal Disorders Nausea, Vomiting, Diarrhea, Abdominal Discomfort
Renal and Urinary Disorders N/A

Serious and Conditional Safety Considerations

The most significant documented risks are conditional, meaning they are primarily associated with specific patient predispositions. Official labeling identifies rare but serious adverse reactions, including Acute Oxalate Nephropathy (kidney stone formation) and Haemolysis (red blood cell destruction). These events are specifically noted in individuals with pre-existing conditions such as severe renal impairment or Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

Safety restrictions also note that due to its chemical properties, the medicine can increase the absorption of iron, which requires caution in patients with conditions like haemochromatosis. Furthermore, high doses of the substance may interfere with the results of certain clinical laboratory tests (e.g., glucose, occult blood), potentially leading to misleading readings. The regulatory framework emphasizes that risks are predominantly concentrated in these defined, vulnerable populations.

Overdose and Emergency Response

Documented Overdose Manifestations

Overdose with Upsa C (Sodium Ascorbate) is documented in regulatory labeling with distinct presentations. Non-severe manifestations include gastrointestinal disturbances such as diarrhoea, nausea, vomiting, and stomach cramps, and may also involve headache. Massive overdosage, however, is associated with serious outcomes primarily affecting the urinary system. These severe effects can include the formation of renal oxalate calculi (kidney stones), acute or chronic oxalate nephropathy, and, in rare cases, acute renal failure.

Seeking Urgent Medical Help

Immediate medical attention is required for any suspected overdose. Official regulatory guidance mandates contacting Poison Control or emergency services immediately if the affected person shows life-threatening signs, such as collapse, seizure activity, or severe difficulty breathing.

Management procedures described in prescribing information focus on supportive measures. Symptomatic treatment and general supportive measures are employed as required. Gastric lavage may be considered if the ingestion was recent. No specific antidote is documented for Ascorbic Acid overdose.

Population-Specific Overdose Considerations

Specific populations carry heightened risks for severe complications. Individuals with Glucose-6-phosphate dehydrogenase (G6PD) deficiency are at increased risk for haemolytic anaemia and metabolic acidosis. Patients with existing renal impairment or those who are geriatric or pediatric (under 2 years old) may require closer monitoring due to an increased risk of oxalate-related kidney complications.

Therapeutic Uses of Upsa C

What Upsa C Treats: Main Uses and Benefits


This product is applied across therapeutic domains where short-term symptomatic assistance is needed, primarily focusing on conditions marked by temporary physiological strain or systemic imbalance. It is commonly used to help with symptoms related to transient physical and mental fatigue, to support the immune system during periods of increased physiological stress, and for the specific management of Ascorbic Acid deficiency (Scurvy).

The product is relevant for conditions characterized by symptoms related to systemic imbalance and temporary functional strain. When symptoms, such as exhaustion or feeling run-down, interfere with daily functioning, the medication provides supportive relief.

“Its application is relevant for managing symptoms that interfere with daily comfort, and offers symptomatic relief that may help patients cope more steadily with symptom fluctuations.”

In clinical scenarios, it is often used during phases when symptoms become more noticeable, providing support that helps ease the overall symptom burden. It assists with maintaining functional stability and supports the patient during difficult episodes by easing distress.

Quick Fact: Relief for Symptoms related to fatigue and nutritional deficiency

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Upsa C — Official Regulatory Information

The eligibility profile for high-dose Sodium Ascorbate is strictly defined by regulatory documents, identifying specific populations for whom use is restricted or prohibited. The high-dose effervescent formulation is typically intended for adults.

Eligibility scope
Populations for whom use is contraindicated
Patients with known hypersensitivity to the active substance or excipients.
Patients with severe or terminal renal insufficiency (dialysis) [Source 2.2].
Populations for whom use is restricted
Renal disease or history of oxalate kidney stones: Use is restricted, as high doses may increase the risk of oxalate nephropathy [Source 1.2].
Glucose-6-phosphate dehydrogenase (G6PD) deficiency: Use is restricted to the Recommended Dietary Allowance (RDA) due to the risk of hemolysis [Source 1.1].
Blood disorders such as Hemochromatosis [Source 1.2].

| Age-related eligibility rules | | Children/Adolescents: The high-strength 1000 mg dose is generally not recommended for this population [Source 2.2]. | | Infants (under 2 years) and Geriatric patients: May be at increased risk of oxalate nephropathy [Source 1.2]. |

| Pregnancy and lactation eligibility status | | Use is allowed, but dosage must not exceed the specific Recommended Dietary Allowance (RDA) or Adequate Intake (AI) for the maternal period [Source 2.6, 1.2]. |

Connection to the overall eligibility profile

Official regulatory documents define who can use this medicine by establishing clear restrictions on dosage and administration for patients with specific metabolic, renal, and hematological conditions. These restrictions ensure that the drug's use is limited to populations where the risk factors are minimized. The high-dose product is designated as not recommended for children, and its use is strictly conditional during pregnancy, lactation, and in individuals with kidney impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Ascorbic Acid through specific pharmacokinetic and pharmacodynamic constraints on co-administration.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Substance / Class Official Interaction Pattern
Deferoxamine (Chelation Therapy) Co-administration is avoided in patients with cardiac failure due to the risk of cardiac dysfunction. A mandatory one-month timing delay is required after starting chelation therapy before administering Ascorbic Acid.
Amphetamine and pH-Sensitive Drugs Ascorbic Acid causes urine acidification, resulting in decreased serum levels and altered elimination of these substances.
Aluminum-Containing Medicines Administration increases the systemic exposure to aluminum by enhancing gastrointestinal absorption.
Warfarin (Anticoagulant) High doses of Ascorbic Acid may lower the body’s pharmacologic response to this medicine.

Other Documented Restrictions

  • Iron (Non-Heme): The substance enhances the absorption of non-heme iron from the gastrointestinal tract, a pattern noted in official documents.
  • Sodium-Restricted Diets: The sodium content in the effervescent tablet formulation must be considered for patients who require dietary sodium limitations.
  • Population-Specific Caution: High-dose use carries a risk of oxalate stone formation heightened in patients with kidney impairment. Use is also restricted in patients with G6PD deficiency due to risk of severe hemolysis.

Mechanism of Action

How Upsa C Works

The mechanism of action of Upsa C (ascorbic acid) centers on its role as a biological electron donor, influencing critical enzyme function and cellular stability.


Enzyme Cofactor and Tissue Structure

This domain covers ascorbic acid's function as a cofactor that supports the active state of several metalloenzymes, specifically those required for the final maturation and stabilization of collagen. This mechanism contributes to the stabilization of connective tissues, including skin, blood vessels, and bone, through structural maintenance.

Antioxidant Shield and Cellular Protection

This mechanistic domain highlights ascorbic acid's action as a reducing agent, enabling it to donate electrons to directly reduce free radicals and reactive oxygen species (ROS) in aqueous cellular environments. The mechanism influences cellular redox balance, resulting in the reduction of oxidative compounds that can cause structural damage.

Modulating Mineral Absorption

This domain describes the chemical role in the digestive tract, where it increases the bioavailability of non-heme iron by reducing poorly absorbed forms of dietary iron ( Fe^3+) into the readily absorbed form ( Fe^2+). This action facilitates the increased availability of an element required for subsequent hemoglobin synthesis and oxygen transport mechanisms.

Dosage and Administration Information

Official Administration Guidelines: How to Use Upsa C

The administration of Upsa C (1000 mg) is based on parameters that define the route, preparation, and standard dosing frequency, focusing on conditions related to Vitamin C deficiency and increased physiological need.

Dosage and Administration Protocol

The medicine is designed for the oral route of administration. The 1 g product is typically supplied as an effervescent tablet, which requires mandatory preparation before ingestion. The tablet must be fully dissolved in a glass of water before being consumed.

Usage Parameter Regulatory Instruction
Standard Adult Dose 1000 mg (1 g) once daily for adults and adolescents (usually ge 15 years).
Maximum Dose Should not exceed 1000 mg per 24-hour period.
Frequency The standard regimen is once daily administration.
Timing Constraint Instructions advise that the dose should not be taken late in the day due to a practical, stimulating effect.
Special Considerations Patients following a sodium-restricted diet must account for the sodium content inherent in the Sodium Ascorbate formulation.

Course of Use and Age Restrictions

Treatment is typically administered over the period of need or until deficiency symptoms abate, which often involves a minimum course of at least two weeks for deficiency states. The 1 g strength is restricted to the adult and older adolescent population; lower, non-effervescent forms are available for children.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Upsa C

The research evidence for the active ingredient, Sodium Ascorbate, focuses primarily on its established nutritional and biological functions as explored in randomized controlled trials (RCTs), systematic reviews, and mechanistic studies. The evidence is generally categorized by the condition or physiological process studied, rather than singular clinical outcomes.


Evidence for Correcting Vitamin C Deficiency (Scurvy)

The foundational research for the active ingredient in Upsa C was studied for conditions characterized by fluctuating or episodic manifestations related to confirmed Vitamin C deficiency. The evidence was evaluated in studies focusing on populations with confirmed, severe deficiency. Researchers monitored biochemical markers, such as the levels of Vitamin C found in the blood, which are outcomes related to systemic or functional imbalance. The necessity of supplementation in cases of confirmed severe deficiency is extensively documented in scientific literature, though recent research focuses mainly on deficiency within subgroups with chronic diseases.


Research on Common Cold Symptoms and Physiological Stress

Research examined the use of the active ingredient during periods of heightened symptom activity, specifically focusing on the common cold. Studies explored both the regular, prophylactic use and the therapeutic use (at symptom onset). Findings describe patterns observed in the studies that regular supplementation was associated with outcomes related to symptom intensity or variability (duration and severity) across many populations studied. However, studies observing regular supplementation reported that outcomes related to the incidence of colds in the general population were mixed. Evidence is still emerging for therapeutic dosing, and the certainty remains low for non-deficiency related fatigue outcomes due to mixed findings and limited long-term data.

Key Studies & References

  1. Ascorbic acid enhances the expression of type 1 and type 4 collagen and SVCT2 in cultured human skin fibroblasts (Mechanistic Study)
  2. Scurvy: Symptoms, Causes & Treatment (Clinical Guideline/Authoritative Review)
  3. Vitamin C deficiency - Symptoms, diagnosis and treatment (Clinical Guideline/Authoritative Review)

Frequently Asked Questions (FAQ)

Common questions about Upsa C (FAQ)

Q: Is Upsa C used for conditions other than its primary approved use?

Official regulatory documents state that the therapeutic use of Upsa C is primarily intended for the prophylaxis and treatment of ascorbic acid deficiency, commonly known as scurvy. While research may examine other uses, the regulatory scope focuses on correcting this specific deficiency state.

Q: What is the difference between Upsa C and other similar products I see at the pharmacy?

Upsa C's formulation contains Sodium Ascorbate, which is a buffered form of Vitamin C. Other products available at the pharmacy may contain different active ingredients (like Zinc), vary in dosage strength (such as 500 mg versus 1000 mg), or come in different forms (like chewable tablets instead of effervescent tablets).

Q: Does Upsa C contain any ingredients that might be considered controversial?

Official product information lists all ingredients, including excipients. Due to its effervescent nature, the tablets often contain a high level of sodium, which is a factor to be aware of for individuals following sodium-restricted diets. They may also contain common excipients like sorbitol or certain colorings (e.g., orange yellow or azorubine).

Q: Can people with a history of heart problems use Upsa C?

Regulatory text notes a conditional risk and the need for monitoring heart function for patients receiving chelation therapy (Deferoxamine) who have cardiac failure, as co-administration can increase risk. Regulatory labels do not provide general eligibility for all other specific heart conditions.

Q: Is Upsa C appropriate for older adults (seniors)?

Regulatory documents indicate that patients in the older adult population may have an increased potential for adverse effects, such as renal toxicity, especially when the medicine is used with certain pain relievers like Nonsteroidal Anti-inflammatory Drugs (NSAIDs).

Q: What is known about the long-term safety profile of Upsa C?

Official safety summaries state that long-term intake of high doses, particularly above 2000 mg daily, increases the risk of negative effects, including the formation of calcium oxalate kidney stones. Furthermore, prolonged high-dose use may potentially lead to a state of tolerance.

Q: Have there been any big studies recently about the effectiveness of Upsa C?

Recent clinical investigations have focused on exploring the effect of daily doses when added to existing treatment regimens. For example, studies have examined the combined effects of the drug with antihypertensive medications, with results often showing modest or mixed clinical findings.

Q: Why is the mechanism of action of Upsa C considered complicated?

The mechanism is described as complex because the drug has multiple roles in the body. It simultaneously acts as a co-factor for various enzyme systems and a powerful reducing agent (antioxidant). These dual functions allow it to influence many biological processes, including collagen formation and iron absorption.

Q: Can Upsa C be taken with a cold or flu medicine?

Regulatory documents state that the substance can cause urine to become acidic, which may alter how the body reabsorbs other medicines. Because many cold and flu drugs are sensitive to changes in urine pH, co-administration may affect the level or therapeutic effect of those products.

Q: Why is Upsa C sometimes combined with other active ingredients in combination products?

Official product information confirms that Upsa C is available in combination products (for example, with Zinc). This is typically done to address multiple nutritional deficiencies or physiological needs simultaneously in one product, according to the product's intended purpose.

Q: What does the FDA classification for Upsa C mean in terms of safety?

The active ingredient, Sodium Ascorbate, is often classified as Generally Recognized as Safe (GRAS) by the FDA in food regulations at certain consumption levels. The 1000 mg dosage form itself is generally classified as an Over-the-Counter (OTC) Vitamin or Mineral product.

Q: Are there any common reasons patients stop taking Upsa C?

The common undesirable effects listed in regulatory documents are dose-dependent gastrointestinal issues. These include nausea, diarrhea, and abdominal cramping, especially when taking doses above 2000 mg per day. These types of side effects are often reported as reasons for discontinuation.

Q: Is Upsa C generally considered a short-term or long-term treatment option?

The duration of therapy is defined by the patient’s physiological need, which is typically until the deficiency symptoms have resolved or for the period where the increased need persists. This course may involve a minimum period or a longer regimen.

Q: Why is Upsa C available over the counter in some places but requires a prescription in others?

While the 1000 mg dose is often classified as an Over-the-Counter (OTC) product in certain jurisdictions, the specific regulatory framework and classification rules vary widely by country. The official documents for the drug itself do not typically detail the specific rationale for these national differences in prescription status.

Q: How quickly am I supposed to feel an effect after taking Upsa C?

Regulatory documents describe the pharmacokinetics of the substance, noting that it is readily absorbed from the digestive tract and the half-life averages 2.9 hours. However, the time required to feel a clinical or symptomatic effect is not specified in the official information.

Q: Is it normal to feel a little dizzy when first starting Upsa C?

Official regulatory documents state that the substance has no known effect on a person's ability to drive or use machinery. This statement implies that the central nervous system side effects often associated with dizziness are not expected adverse reactions.

Q: How does Upsa C interact with common pain relievers like ibuprofen?

Official labeling for the substance indicates that combining large doses of Vitamin C with Nonsteroidal Anti-inflammatory Drugs (NSAIDs), which include ibuprofen, may raise the risk of developing certain kidney problems. This interaction is noted in labeling as a conditional risk that should be managed.

Q: Does Upsa C change how birth control pills work?

Official interaction documents report that the substance may interact with oral contraceptives that contain estrogen. It has the potential to raise the levels of estrogen in the body. Additionally, taking oral contraceptives may also decrease the rate at which the body excretes the active ingredient.

Q: Are people with diabetes allowed to take Upsa C?

While diabetes is not listed as a formal contraindication in official documents, high doses of the substance may interfere with the results of certain clinical laboratory tests. This interference includes potentially producing false readings in some home blood glucose monitors.

Q: How long does Upsa C stay in my system after the last dose?

According to the pharmacokinetics section of official regulatory documents, the active ingredient is water-soluble. Any amount above what the body needs is rapidly eliminated into the urine, with an average half-life of approximately 2.9 hours.

Q: If I stop taking Upsa C, will my original symptoms come back immediately?

Official warnings note that if high doses are taken for a prolonged period, the body may induce a state of tolerance. If the intake is then rapidly reduced or completely withdrawn, deficiency symptoms may return.

Q: Are there any known issues with taking Upsa C with blood pressure medication?

Clinical studies have explored the combined use of the substance with antihypertensive medications. These studies have generally shown inconsistent or mixed reports regarding whether the combination has any noticeable effect on blood pressure control.

Q: What information should I read carefully before starting Upsa C?

Official documents outline warnings related to several key risks that may require attention. These include the potential for kidney stone formation, the risk of deficiency symptoms if high doses are stopped suddenly, and the possibility of interference with the results of certain laboratory tests.

Q: Why does the packaging for Upsa C warn against mixing it with alcohol?

Official drug interaction documents specifically list alcohol among the substances that may impact the drug's effectiveness. Alcohol is indicated to induce tissue desaturation, which means it can lower the body's levels of the active ingredient.

How should Upsa C be stored and disposed of?

The official regulatory requirements for storing and disposing of Upsa C effervescent tablets focus on protecting the product from environmental degradation.

Storage Requirements

  • Temperature and Protection: The product must be stored at a temperature not exceeding 25 C or 30 C and must be protected from light and moisture. Storage in a cool, dry place is essential.
  • Packaging: The tablets must be kept in the original container, and the container must be kept tightly closed after each use to protect the contents from humidity.
  • Child Safety: As with all medicines, it is mandatory to keep this product out of the sight and reach of children.

Disposal Instructions

Any unused or expired Upsa C and its waste material must be disposed of in accordance with local regulations and requirements. Official labeling does not specify unique hazardous waste handling but defers to local pharmaceutical waste procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Upsa C found in:

A-Z Index: